Pharmacy Articles

Pharmacy

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

A new drug designed to “seek and destroy” common cancers such as breast, prostate, endometrial, pancreatic, ovarian, skin and testicular cancers is being tested. The Phase 1 clinical trial will help determine if EP–100 is safe and effective for use among patients with solid cancer tumors, with fewer side effects than chemotherapy or radiation treatment.

   

Today in Popular Press...keeping you current

Easily led ash-tray: Adolescent smokers prone to drug abuse
EurekAlert, 12/14/09

Pathological gambling may be successfully treated with medications for substance addiction
EurekAlert, 12/11/09

How calorie-restricted diets fight obesity and extend life span
EurekAlert, 12/10/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address